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SUMMARY 
Preparation of no-carrier-added fluorine-18 labeled GBR 12909 (1-[2-(bis(4- 
fluorophenyl)methoxy)ethyl]-4-(3-phenylpropyl)piperazine), a specific and high affinity 
inhibitor of dopamine reuptake, is described. 4-Fluoro-4’-[~8Flfluorobenzophenone 
was prepared by [IBFIfluoride ion substitution of the corresponding trimethyl- 
ammonium trifluoromethanesulfonate salt. The [1sF]benzophenone was reduced to 
the benzhydrol, chlorinated, then used to alkylate 1-(2-hydroxyethyl)-4-(3-phenyl- 
propy1)piperazine to yield [18F]GBR 12909 in high specific activity (>2000 Ci/mmol) 
and overall yields of 10-16% (corrected, 140 min synthesis). 
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INTRODUaION 
We have recently reported the synthesis of “8FIGBR 13119 (Fig. l), a specific, high 
affinity inhibitor of the dopamine reuptake system (1,2). Although suitable for 
extensive animal use, the application of this radiotracer to human studies proved 
troublesome, due to the lack of pharmacological and toxicological data. A closely 
related compound, GBR 12909 (1-[2-(bis(4-fluorophenyl)methoxy)ethyll-4-~3- 
phenylpropyl)piperazine), is in clinical trials and has been extensively studied as to its 
pharmacology and toxic properties in both animals and humans (3,4). We describe here 
the synthesis of GBR 12909 (Fig 1) in fluorine-18 form suitable for human use. 
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I X = H, Y = F GBR 13119 
Y 
X = F, Y = F GBR 12909 
Figure. 1 
EXPERIMENTAL 
Materials and Methods. The following chemicals were obtained from the 
indicated sources and used without further purification: thionyl chloride, lithium 
aluminum hydride (1 M in THF), carbon disulfide, mesitylene, methyl 
trifluoromethanesulfonate, N,N-dimethylaniline, tin(1V) chloride, and 4- 
fluorobenzoyl chloride from Aldrich Chem Co. N-(2-Hydroxyethyl)-N-(3-phenyl- 
propy1)piperazine was prepared per literature methods (5). High specific activity 
(approx. 50,000 Ci/mmol) [18F]fluoride ion was prepared by proton bombardment of 
“801water (95-99% enrichment, Isotec) as previously described (6). Thin layer 
chromatography was done using plastic-backed silica gel plates (Merck), and preparative 
layer chromatography using 2 mm silica gel plates (Merck). Melting points were 
determined with a Mel-Temp apparatus and are reported uncorrected. NMR spectra 
were done using a Bruker WM360 spectrometer, and mass spectra were determined 
using a VG Instruments Model 70-250s mass spectrometer utilizing fast atom 
bombardment with 3-nitrobenzyl alcohol as matrix. 
4-Fluoro-4‘-N,N-dimethylaminobenzophenone (1). A 250 ml 3-neck round 
bottom flask was equipped with a mechanical stirrer, a reflux condenser with CaC12 
drying tube, and a dropping funnel, and an argon atmosphere introduced. To this were 
added 21.5 g (82.5 mmol) of SnC14 and 100 ml of dry CS2. The mixture was cooled to 5 
OC (ice-water) and vigorously stirred while N,N-dimethylaniline (5.0 g, 41.26 mmol) 
was added dropwise over 10 min. The dropping funnel was then washed with 10 ml of 
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CS2. To the yellow slurry was then added 4-fluorobenzoyl chloride (6.54 g, 41.26 mmol) 
dropwise over 15 minutes. After addition was complete, the mixture was warmed to 
room temperature and finally refluxed for one hour. The now dark black-green 
mixture was cooled to 5 OC and ice (50 g) and then water (109 ml) added; a dark green oil 
separated at this point. Steam was then passed through the mixture to remove the 
carbon disulfide and unreacted N,N-dimethylaniline. The residue was cooled to 5 OC 
and filtered to yield a dark blue-green solid. The solid was suspended in 200 ml of 
water at 50 OC and then filtered, and this process was repeated twice. The remaining 
green solid was washed with water and cold methanol (100 ml) to yield 3.0 g of crude 
product. 
The crude material was dissolved in 100 ml of chloroform and filtered. The 
solution was washed with 3 x 35 ml portions of 7.5% aqueous hydrogen peroxide 
containing 1.0 g NaOH per portion. Finally, the chloroform solution was washed with 
100 ml water, dried (MgS04), and evaporated to give 0.5 ml of a yellow crystalline 
product. This was dissolved in 10 ml of acetone, heated to reflux, and filtered hot. The 
filtrate was then allowed to cool overnight. The yellow crystals of 4-fluoro-4'-N,N- 
dimethylaminobenzophenone were collected by filtration. TLC showed a small 
impurity, which was separated by silica gel preparative layer chromatography (2 mm 
silica gel, CH2C12) to afford 600 mg (6% yield) of the desired 4-fluoro-4'-N,N- 
dimethylaminobenzophenone 1: m.p. 107-109 OC; IH NMR (CDC13) 6 2.97 (s, 6H, 
N(CH3)2), 6.57-6.59 (d, 2H, ArH ortho to amine), 7.0-7.05 (dd, 2H, ArH ortho to fluorine), 
7.64-7.68 (m, 4H, ArH ortho to carbonyl). 
4-Fluoro-4'-N,N,N-trimethylammoniobenzophenone (2) .  Under an Ar 
atmosphere, methyltrifluoromethanesulfonate (63.3 pl, 0.56 mmol) was added to a 
solution of dimethylaminobenzophenone 1 (127 mg, 0.523 mmol) in 10 ml of CH2C12. 
The yellow solution was stirred overnight, then diethyl ether added. The white 
precipitate which formed was collected and recrystallized to give the desired 
trimethylammonium salt 2: yield 85 mg, 40%; m.p. 84-86 OC; Mass spec (FAB) m/z  258 
(positive ion, calcd for C16H17NFO+, 258); m/z 149 (negative ion, calcd for CF3S03-, 149). 
Analysis: Calcd for C ~ ~ H I ~ N O ~ F ~ S  . 1 / 2  H20, C, 49.04; H, 4.36; N, 3.36. Found: C, 48.96; 
H, 4.96; N, 3.24. 
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4-f~~FIFluoro-4'-fluorobenzophenone (3). To a solution of no-carrier-added 
"BFlfluoride ion in DMSO (resolubilized using 1 mg K2CO3 and 5 mg Kryptofix-222, 
as per previous methods (1)) was added 1 mg of trimethylammonium salt 2 .  The 
solution was heated at 155 OC for 20 min, then cooled and an aliquot removed. The 
aliquot was diluted with water and the product extracted into diethyl ether: yields 60- 
94%, TLC silica gel (8/2 pentane /ether) Rf = 0.57. The bulk of the reaction was not 
worked up but used in the next step. 
4-[~~FlFluoro-4 ' - f iuorobenzhyd~ol  (4). The solution of crude [1*F]benzophenone 
3 in DMSO was cooled (0-5 OC, ice-water) and lithium aluminum hydride (0.1 ml, 100 
pmol) added via syringe. After 1 min, the reaction was quenched by dropwise addition 
of 2N HC1, and then 10 ml of 2 N HC1 added and the aqueous mixture passed through a 
C18 Sep-Pak. The Sep-Pak was washed with water (5 ml), then the product eluted with 
2 ml of CH2C12 which was then dried (MgS04). Yield 55-85% (from [18F]fluoride); TLC 
(silica gel, 7/3 hexane/ethylacetate) Rf = 0.16. 
4-118FIFluoro-4 '-fiuorobenzhydryl chloride (5).  The solution of [18F]benzhydrol 4 
was evaporated (slow N2 flow) and 300 pl of SOC12 added. The solution was heated (100 
OC, closed vessel) for 20 min, cooled, and the thionyl chloride evaporated to yield crude 
chloride 5; yields 80-95 % (from alcohol 4); TLC (silica gel, 7 / 3  hexane/ethylacetate) Rf 
= 0.50. 
[18FlGBR 12909 ~(1-i2-~bis(4- f iuorophenyI~methoxy~ethyl~-4-~3-phenylpropyl~-  
pipermine). To the residue of ['gFIchloride 5 was added 10 mg of N-(2-hydroxyethyl)-N- 
(3-phenylpropy1)piperazine in 50 p1 mesitylene, and the solution heated at 155 O C  for 25 
min. The vessel was cooled and the brown oil dissolved in 0.5 ml of methanol. The 
methanol was then diluted with 10 ml of water and passed through a C18 Sep-Pak. The 
Sep-Pak was washed with water, then the products eluted with 10 ml of pentane. The 
pentane was dried (MgSO4) and then passed through a silica gel Sep-Pak. The silica gel 
was washed with 2 x 20 ml of 1/1 pentane/CH2C12, and the product [IgFIGBR 12909 
eluted with 10 ml of 5% methanol/CH2C12. Yield of condensation reaction 25-60%; TLC 
(silica gel, 95/5 CH~C12/methanol) Rf = 0.31; HPLC, Phenomenex C18 column, 0.45 x 15 
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cm, 60/40 acetonitrile/0.065 M N h O A c  (3 ml tetrahydrofuran/liter water) , 2 ml/min 
flow: GBR 12909, Product identity was 
confirmed by comparison to a known standard of GBR 12909 obtained from NOVO 
Industri, A/S (also available from Research Biochemicals Incorporated). Overall yields 
of [18F]GBR12909 ranged from 10-16% (corrected for decay) with a synthesis time of 120- 
140 min. For biological studies the product was prepared for injection by evaporation of 
the organic solvent and dissolution in dilute acidic saline (pH 5.5). 
Rt = 14.0 min; piperazine, Rt = 3.5 min. 
RESULTS AND DISCUSSION 
The synthesis of “8FIGBR 12909 follows the same synthetic route as we have 
previously developed for “8FIGBR 13119 (1). The necessary precursor, 4-fluoro-4- 
trimethylammoniumbenzophenone triflate (21, was prepared by the method shown in 
Figure 2. Friedel-Crafts acylation of N,N-dimethylaniline with 4-fluorobenzoyl 
0 
1 
CF,S03CH3 i 
0 
Fig. 2 
chloride gave multiple acylation products, from which the desired 4-fluoro-4’-N,N- 
dimethylaminobenzophenone 1 was isolated by crystallization and silica gel 
preparative layer chromatography. Although this provided a direct route to the tertiary 
amine 1, the yield was very low and alternative syntheses of 1 were examined. The use 
of anhydrous aluminum chloride as the Friedel-Crafts catalyst gave, instead of the 
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desired mono-acylation product 1, a good yield (35%) of a product identified by NMR 
(*H and 13C) and mass spectroscopy (m/e 365, M+) as a di-acylation product. This bis- 
acylation product was obtained even in the presence of excess N,N-dimethylaniline. 
At this time we are uncertain as to whether the second acyl group has added ortho- or 
meta- to the dimethylamine substituent; this unusually facile bis-acylation reaction is 
under further study. An alternative route using Friedel-Crafts acylation of acetanilide, 
followed by hydrolysis to the primary amine and methylation, was attempted but did 
not prove advantageous, due to unexpected difficulties in the hydrolysis step. 
The N,N-dimethylamine 1 isolated by chromatography was then alkylated 
(methyl trifluoromethanesulfonate) to give the trimethylammonium salt 2, which was 
separated from traces of the starting material by recrystallization. 
/ 2 
1. LAH 
2. soc12 
3. N-hydroxyethyl- 
N-phenylpropyl- 
[l *F]GBR 12909 /I piperazine 
Fig 3 
Reaction of the trimethylammonium salt 2 with NCA [18Flfluoride ion 
proceeded smoothly to give the benzophenone 3 (Fig. 3) in 60-94% yields (no attempts 
were made to isolate the other possible product, arising from isotopic exchange of 
fluorine). Reduction, chlorination, and condensation with N-(2-hydroxyethyl)-N-(3- 
phenylpropy1)piperazine to give [*8F]GBR 12909 proceeded analagously to the synthesis 
of [1*F]GBR 13119 (1). The final product was purified by C-18 and silica gel SEP-PAKS, 
and analyzed by HPLC and TLC. Radiochemical purity was >95%, and chemical purity 
excellent (10-40 microgram amounts of N-(2-hydroxyethyl)-N-(3-phenyl- 
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propyllpiperazine were observed in some preparations). Specific activity, estimated by 
HPLC analysis at end of synthesis, was in excess of 2,000 Ci/mmol (limit of detection of 
UV detector utilized). Overall yields were 10-16% (corrected for decay) in a total 
synthesis time of 120-140 minutes. 
Preliminary in vivo study of regional brain distribution in mice shows striatal 
uptake (2.4 1.2 %ID/g) and striatum/cerebellum ratios (3.13 2 1.01) determined at 1 h 
which are essentially identical to those obtained with “8FIGBR 13119 (7). Further 
animal and human studies with this radiopharmaceutical will be reported in due 
course. 
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